Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label previous answer version answering member constituency answering member printed answering member label
tabling member	label

Search

1056636

registered interest
date	07/02/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Prescriptions: Fees and Charges
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether he is taking steps to exempt people with diagnosed long-term mental health illnesses from prescription charges.
tabling member constituency	Crewe and Nantwich
tabling member printed	Laura Smith
uin	218348
answer	answer is ministerial correction date of answer 15/02/2019 answer text <p>The Department has no current plans to amend the list of medical conditions that provide exemption from National Health Service prescription charges, as extensive arrangements are in place to ensure that people, including those with mental health illnesses, can access affordable prescriptions.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 15/02/2019 11:11:14 answering member 4067 label Biography information for Steve Brine
tabling member	4648 label Biography information for Laura Smith

1056727

registered interest
date	07/02/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Human Papillomavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will consider making it a priority of his Departmental to extend the HPV vaccination programme to include male boys.
tabling member constituency	Hendon
tabling member printed	Dr Matthew Offord
uin	218285
answer	answer is ministerial correction date of answer 15/02/2019 answer text <p>The Department announced on 24 July 2018 that it is extending the human papillomavirus girls’ vaccination programme to boys and is working with Public Health England and NHS England to roll this out as soon as possible during the 2019/20 academic year.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 15/02/2019 11:12:01 answering member 4067 label Biography information for Steve Brine
tabling member	4006 label Biography information for Dr Matthew Offord

1056728

registered interest
date	07/02/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Human Papillomavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment the Department has made of the effectiveness of extending the HPV vaccination programme to male boys to reduce incidents of cervical cancer in women.
tabling member constituency	Hendon
tabling member printed	Dr Matthew Offord
uin	218286
answer	answer is ministerial correction date of answer 15/02/2019 answer text <p>In its review of the modelling of the impact and cost effectiveness of vaccinating adolescent boys the Joint Committee on Vaccination and Immunisation (JCVI) noted that by vaccinating boys as well as girls, additional cases of cervical and non-cervical cancer will be prevented in women.</p><p> </p><p>The JCVI statement, including a review of the evidence, is available at the following link:</p><p> </p><p><a href="https://www.gov.uk/government/publications/jcvi-statement-extending-the-hpv-vaccination-programme-conclusions" target="_blank">https://www.gov.uk/government/publications/jcvi-statement-extending-the-hpv-vaccination-programme-conclusions</a></p> answering member constituency Winchester answering member printed Steve Brine question first answered 15/02/2019 11:13:37 answering member 4067 label Biography information for Steve Brine
tabling member	4006 label Biography information for Dr Matthew Offord

1056731

registered interest
date	07/02/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cervical Cancer: Screening
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will consider making cervical screening available on the NHS for women under the age of 25.
tabling member constituency	Hendon
tabling member printed	Dr Matthew Offord
uin	218287
answer	answer is ministerial correction date of answer 15/02/2019 answer text <p>In 2012 the UK National Screening Committee (UK NSC) which advises ministers and the National Health Service in all four countries about all aspects of screening policy, recommended that the age of the first invitation for cervical screening should be age 25. This was based on evidence that there is little benefit for screening women below this age.</p><p> </p><p>Cervical cancer in women under the age of 25 is very rare with 2.6 cases per 100,000 women and younger women often undergo natural and harmless changes in the cervix that screening could identify as cervical abnormalities, and in most cases these abnormalities resolve themselves without any need for intervention.</p><p> </p><p>Further, the vaccination against human papillomavirus (HPV), introduced in 2008, is now routinely recommended for all girls aged 12 to 13 years and the first cohort of teenage girls to receive the HPV vaccination in year 8 (those born since September 1996) will turn 23 this year and become eligible for routine screening in two years’ time. The impact the vaccination will have on the number of abnormalities detected through routine cervical screening will be carefully monitored.</p><p> </p><p>If a woman of any age including those under 25, has unusual symptoms, usually abnormal bleeding, they should consult their general practitioner immediately. They will be treated under the NHS and initially offered a speculum examination in accordance with the guidance for primary care on the management of young women who present with gynaecological symptoms.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 15/02/2019 11:15:08 answering member 4067 label Biography information for Steve Brine
tabling member	4006 label Biography information for Dr Matthew Offord

1056732

registered interest
date	07/02/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Lumacaftor/ivacaftor
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what progress his Department has made on securing the availability of Orkambi on the NHS for patients with cystic fibrosis.
tabling member constituency	Sheffield, Brightside and Hillsborough
tabling member printed	Gill Furniss
uin	218344
answer	answer is ministerial correction date of answer 12/02/2019 answer text <p>The National Institute for Health and Care Excellence (NICE) and NHS England are leading the dialogue with Vertex Pharmaceuticals around access to their portfolio of cystic fibrosis medicines. It is critical that Vertex now re-engages fully with the NICE appraisal process and gives serious consideration to the portfolio deal offer that NHS England made at the end of July. This deal would provide immediate access for patients to all Vertex licensed medicines and future pipeline products once licensed and in advance of the individual NICE appraisals concluding.</p><p> </p><p>The Government fully supports the approach that NICE and NHS England are adopting. It is crucial that patients have access to the most effective and innovative medicines at a price that represents value to the National Health Service.</p><p> </p><p>NHS England has proposed its best offer ever for a drug. This offer, in the region of £500 million over five years, is the largest ever commitment of its kind in the 70-year history of the NHS and would guarantee immediate and expanded access to both Orkambi and the drug Kalydeco for patients who need it. Whilst it is disappointing that Vertex has not taken up NHS England’s offer, we are encouraged that there is continued dialogue between all parties.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 12/02/2019 15:33:24 answering member 4067 label Biography information for Steve Brine
tabling member	4571 label Biography information for Gill Furniss

1056733

registered interest
date	07/02/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cystic Fibrosis: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure the NHS is able to offer all treatment options for patients with cystic fibrosis.
tabling member constituency	Sheffield, Brightside and Hillsborough
tabling member printed	Gill Furniss
uin	218345
answer	answer is ministerial correction date of answer 12/02/2019 answer text <p>Specialised services for the support and treatment of patients with cystic fibrosis (CF) are commissioned nationally by NHS England. CF services are delivered in about 20 Paediatric Cystic Fibrosis Centres and about 20 Adult Cystic Fibrosis Centres. There are separate service specifications for adults and children. These specifications are important in clearly defining what NHS England expects to be in place for providers to offer evidence-based, safe and effective care and treatment. The support equity of access to a nationally consistent, high quality service.</p><p> </p><p>The specifications can be found via the following links:</p><p> </p><p><a href="http://www.england.nhs.uk/wp-content/uploads/2018/08/Cystic-fibrosis-adult.pdf" target="_blank">www.england.nhs.uk/wp-content/uploads/2018/08/Cystic-fibrosis-adult.pdf</a></p><p> </p><p><a href="http://www.england.nhs.uk/wp-content/uploads/2018/07/a01Sb-spec-cystic-fibrosis-child.pdf" target="_blank">www.england.nhs.uk/wp-content/uploads/2018/07/a01Sb-spec-cystic-fibrosis-child.pdf</a></p><p> </p><p>In October 2017, the National Institute for Health and Care Excellence (NICE) published new guidance for the diagnosis and management of CF. This includes specific details on how to monitor the condition and manage the symptoms to improve quality of life. This guidance can be found via the following link:</p><p> </p><p><a href="http://www.nice.org.uk/guidance/ng78" target="_blank">www.nice.org.uk/guidance/ng78</a></p><p> </p><p>NICE is the organisation responsible for assessing the clinical and cost effectiveness of medicines for the National Health Service.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 12/02/2019 15:53:01 answering member 4067 label Biography information for Steve Brine
tabling member	4571 label Biography information for Gill Furniss

1056744

registered interest
date	07/02/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Electronic Cigarettes
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to the Seventh Report of Session 2017-19 of the Science and Technology Committee on E-cigarettes, HC505, what steps he has taken to ensure that the regulatory system for e-cigarettes is risk-proportionate.
tabling member constituency	Windsor
tabling member printed	Adam Afriyie
uin	218246
answer	answer is ministerial correction date of answer 15/02/2019 answer text <p>The Government published its response to the Science and Technology Committee on the 10 December 2018. Good progress is being made on implementing the report’s recommendations: for example, Public Health England will publish its latest annual evidence review on e-cigarettes by the end of March 2019 and NHS England is developing guidance on e-cigarettes for mental health trusts. The Department will continue to monitor progress as part of its monitoring of the delivery of the Tobacco Control Plan for England.</p><p> </p><p>The Government believes in proportionate regulation of e-cigarettes, recognising that they are not risk-free. Through the European Union Tobacco Products Directive 2014/40/EU (TPD), transposed into United Kingdom law by the UK Tobacco and Related Products Regulations 2016 (TRPR), we have introduced measures to regulate e-cigarettes to reduce the risk of harm to children, protect against any risk of renormalisation of tobacco use, provide assurance on relative safety for users, and give businesses legal certainty. This has enabled the UK to implement appropriate standards for products whilst allowing smokers to move to e-cigarettes should they wish.</p><p> </p><p>While the UK Government is a member of the EU it will continue to comply with the requirements of the EU’s TPD. The Government has made a commitment to review the TRPR by May 2021 to consider its regulatory impact. In addition, as announced in the Tobacco Control Plan the Government will review where the UK’s exit from the EU offers us opportunities to re-appraise current regulation to ensure this continues to protect the nation’s health.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 218245 question first answered 15/02/2019 11:10:04 answering member 4067 label Biography information for Steve Brine
tabling member	1586 label Biography information for Adam Afriyie

1056756

registered interest
date	07/02/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Electronic Cigarettes
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether companies are prevented from (a) encouraging smokers to switch to vaping and (b) advertising price reductions for e-cigarettes.
tabling member constituency	Stockton North
tabling member printed	Alex Cunningham
uin	218311
answer	answer is ministerial correction date of answer 15/02/2019 answer text <p>The United Kingdom Tobacco and Related Products Regulations 2016 (TRPR) covers the regulation of e-cigarettes transposed from the European Union’s Tobacco Products Directive. Regulation 38 of the TRPR covers product presentation requirements and defines what can be written on a unit packet and any container pack of the electronic cigarette or refill container. Products may not for example suggest that a particular electronic cigarette or refill container is less harmful than other electronic cigarettes or refill containers; has vitalising, energising, healing, rejuvenating, natural or organic properties; or has other health or lifestyle benefits. These regulations also prohibit price reductions.</p><p> </p><p>The Advertising Standards Authority (ASA) is responsible for monitoring the marketing and advertising of non-broadcast communications for electronic cigarettes. Section 22 of the ASA Committee of Advertising Practice Code concerns the regulation of marketing communications for electronic cigarettes. The code does not allow for medicinal claims but provides advice on how health claims can be made for marketing purposes that are not restricted by regulation.</p><p> </p><p>The Government has made a commitment to review the TRPR by May 2021 to consider its regulatory impact. In addition, as announced in the Tobacco Control Plan the Government will review where the UK’s exit from the EU offers us opportunities to re-appraise current regulation to ensure this continues to protect the nation’s health.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 15/02/2019 11:08:47 answering member 4067 label Biography information for Steve Brine
tabling member	4122 label Biography information for Alex Cunningham

1056765

registered interest
date	07/02/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Dental Services: Fees and Charges
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to the press release entitled, Dentists welcome official investigation into fines hitting vulnerable NHS patients, published on 30 January 2019 by the British Dental Association; what steps his Department is taking to ensure that fear of receiving a fine for ticking the wrong box when claiming for free dental care does not discourage people from low income families from attending the dentist.
tabling member constituency	Barnsley Central
tabling member printed	Dan Jarvis
uin	218312
answer	answer is ministerial correction date of answer 12/02/2019 answer text <p>All National Health Service dental practices are required to display a poster showing patient charges and to offer patients a free leaflet which sets out in detail who is entitled to free NHS dental services. Information on exemptions and support for people who are on a low income can also be found at the following link:</p><p> </p><p><a href="http://www.nhs.uk/healthcosts" target="_blank">www.nhs.uk/healthcosts</a></p><p> </p><p>Eligibility checks are carried out on claims received for exemption from NHS Dental Patient Charges. Where eligibility cannot be verified, patients are asked to confirm their eligibility or to pay the relevant dental charge plus a penalty charge. Patients are, however, able to challenge penalty charges they believe are unjustified.</p><p> </p><p>The Department, NHS Business Services Authority and NHS England have recognised the concern that some patients may not be clear on whether they are exempt from charges and has been working to further improve the information available to patients around eligibility. This includes promoting an easy read patient information booklet, creating an online eligibility checker and developing a national awareness campaign.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 218313 question first answered 12/02/2019 15:25:29 answering member 4067 label Biography information for Steve Brine
tabling member	4243 label Biography information for Dan Jarvis

1055805

registered interest
date	06/02/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Dental Services: Fees and Charges
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that people are not issued with a penalty charge for ticking the wrong box on the claim form when claiming for free dental care.
tabling member constituency	Barnsley Central
tabling member printed	Dan Jarvis
uin	217585
answer	answer is ministerial correction date of answer 12/02/2019 answer text <p>All National Health Service dental practices are required to display a poster showing patient charges and to offer patients a free leaflet which sets out in detail who is entitled to free NHS dental services. Information on exemptions and support for people who are on a low income can also be found at the following link:</p><p> </p><p><a href="http://www.nhs.uk/healthcosts" target="_blank">www.nhs.uk/healthcosts</a></p><p> </p><p>Eligibility checks are carried out on claims received for exemption from NHS Dental Patient Charges. Where eligibility cannot be verified, patients are asked to confirm their eligibility or to pay the relevant dental charge plus a penalty charge. Patients are, however, able to challenge penalty charges they believe are unjustified.</p><p> </p><p>The Department, NHS Business Services Authority and NHS England have recognised the concern that some patients may not be clear on whether they are exempt from charges and have been working to further improve the information available to patients around eligibility. This includes promoting an easy read patient information booklet, creating an online eligibility checker and developing a national awareness campaign.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 217586 question first answered 12/02/2019 11:41:21 answering member 4067 label Biography information for Steve Brine previous answer version 101141 answering member constituency Winchester answering member printed Steve Brine answering member 4067 label Biography information for Steve Brine
tabling member	4243 label Biography information for Dan Jarvis